Regulation of the human SLC25A20 expression by peroxisome proliferator-activated receptor alpha in human hepatoblastoma cells

Biochemical and Biophysical Research Communications

Volumn 389, Issue 3, 2009, Pages 501-505

  Tachibana, Keisuke ^a   Takeuchi, Kentaro ^a   Inada, Hirohiko ^a   Yamasaki, Daisuke ^a   Ishimoto, Kenji ^a,b   Tanaka, Toshiya ^c   Hamakubo, Takao ^c   Sakai, Juro ^c   Kodama, Tatsuhiko ^c   Doi, Takefumi ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Carnitine acylcarnitine translocase; PPAR ; PPRE; SLC25A20; Target gene

Indexed keywords

MEMBRANE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN SLC25A20; TETRACYCLINE; UNCLASSIFIED DRUG; CARRIER PROTEIN; SLC25A20 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LIPID OXIDATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AMINO ACID SEQUENCE; GENETICS; METABOLISM; MOLECULAR GENETICS; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE, TUMOR; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; PPAR ALPHA; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 70449729505     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.018     Document Type: Article

References (19)

1. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, R.M. Evans, The nuclear receptor superfamily: the second decade, Cell 83 (1995) 835-839.
2. K. Tachibana, D. Yamasaki, K. Ishimoto, T. Doi, The role of PPARs in cancer, PPAR Res. 2008 (2008) Article ID 102737, 15 pages, doi:10.1155/2008/102737.
3. S. Mandard, M. Muller, S. Kersten, Peroxisome proliferator-activated receptor alpha target genes, Cell. Mol. Life Sci. 61 (2004) 393-416.
4. K. Tachibana, Y. Kobayashi, T. Tanaka, M. Tagami, A. Sugiyama, T. Katayama, C. Ueda, D. Yamasaki, K. Ishimoto, M. Sumitomo, Y. Uchiyama, T. Kohro, J. Sakai, T. Hamakubo, T. Kodama, T. Doi, Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms, Nucl. Recept. 3 (2005) 3.
5. C. Indiveri, V. Iacobazzi, N. Giangregorio, F. Palmieri, The mitochondrial carnitine carrier protein: cDNA cloning primary structure and comparison with other mitochondrial transport proteins, Biochem. J. 321 (Pt 3) (1997) 713-719.
6. C. Indiveri, A. Tonazzi, F. Palmieri, Identification and purification of the carnitine carrier from rat liver mitochondria, Biochim. Biophys. Acta 1020 (1990) 81-86.
7. M. Huizing, V. Iacobazzi, L. Ijlst, P. Savelkoul, W. Ruitenbeek, L. van den Heuvel, C. Indiveri, J. Smeitink, F. Trijbels, R. Wanders, F. Palmieri, Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient, Am. J. Hum. Genet. 61 (1997) 1239-1245.
8. L. Viggiano, V. Iacobazzi, R. Marzella, C. Cassano, M. Rocchi, F. Palmieri, Assignment of the carnitine/acylcarnitine translocase gene (CACT) to human chromosome band 3p21.31 by in situ hybridization, Cytogenet. Cell Genet. 79 (1997) 62-63.
9. K. Ishimoto, H. Nakamura, K. Tachibana, D. Yamasaki, A. Ota, K.I. Hirano, T. Tanaka, T. Hamakubo, J. Sakai, T. Kodama, T. Doi, Sterol-mediated regulation of human lipin 1 gene expression in hepatoblastoma cells, J. Biol. Chem. 284 (2009) 22195-22205.
10. K. Tachibana, N. Anzai, C. Ueda, T. Katayama, D. Yamasaki, T. Kirino, R. Takahashi, K. Ishimoto, H. Komori, T. Tanaka, T. Hamakubo, Y. Ueda, H. Arai, J. Sakai, T. Kodama, T. Doi, Regulation of the human PDZK1 expression by peroxisome proliferator-activated receptor alpha, FEBS Lett. 582 (2008) 3884-3888.
11. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, R.M. Evans, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature 358 (1992) 771-774.
12. J.D. Tugwood, I. Issemann, R.G. Anderson, K.R. Bundell, W.L. McPheat, S. Green, The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene, EMBO J. 11 (1992) 433-439.
13. S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, W. Wahli, Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting, J. Clin. Invest. 103 (1999) 1489-1498.
14. M.H. Hsu, U. Savas, K.J. Griffin, E.F. Johnson, Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells, J. Biol. Chem. 276 (2001) 27950-27958.
15. U. Varanasi, R. Chu, Q. Huang, R. Castellon, A.V. Yeldandi, J.K. Reddy, Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene, J. Biol. Chem. 271 (1996) 2147-2155.
16. A. Gutgesell, G. Wen, B. Konig, A. Koch, J. Spielmann, G.I. Stangl, K. Eder, R. Ringseis, Mouse carnitine-acylcarnitine translocase (CACT) is transcriptionally regulated by PPARalpha and PPARdelta in liver cells, Biochim. Biophys. Acta 1 (2009) 1, doi:10.1016/j.bbagen.2009.1006.1012. Epub ahead of print, July 3.
17. M.E. Rubio-Gozalbo, J.A. Bakker, H.R. Waterham, R.J. Wanders, Carnitine- acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects, Mol. Aspects Med. 25 (2004) 521-532.
18. F. Djouadi, J. Bastin, PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders, J. Inherit. Metab. Dis. 31 (2008) 217-225.
19. J.P. Bonnefont, J. Bastin, A. Behin, F. Djouadi, Bezafibrate for an inborn mitochondrial beta-oxidation defect, N. Engl. J. Med. 360 (2009) 838-840.